Skip to main content

Table 2 Results of multivariate linear regression for factors predicting the change in best corrected visual acuity (BCVA) in logMAR units at 12 months

From: Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration

Predictor ß p value
Age 0.16 0.019 (*)
Baseline BCVA − 0.42 9.43e-09 (***)
Baseline CRT − 0.0063 0.93
Number of injections − 0.16 0.022 (*)
Presence of SRF 0.014 0.84
Presence of IRF − 0.044 0.54
  1. BCVA best corrected visual acuity; CRT central retinal thickness; SRF subretinal fluid; IRF intraretinal fluid
  2. p  <  0.001 (***), p  <  0.01 (**), p  <  0.05 (*)